CNIO researchers explain the toxicity of USP7 inhibitors, under development for cancer treatment

People With Blood Cancer May Not Be Optimally Protected After mRNA COVID-19 Vaccination

Unlocking new avenues for curing cancer: Cell receptor neuropilin-1 could hold the key

Study: New approach may boost prostate cancer immunotherapies